Modified vaccinia Ankara: potential as an alternative smallpox vaccine

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Lewis H McCurdyBarney S Graham

Abstract

Despite the declaration of smallpox eradication in 1980, the existence of variola stockpiles and the threat of bioterrorism demand that immunity to smallpox through vaccination be maintained. Although the currently available vaccine was used for the most successful medical intervention ever accomplished, it also is associated with side effects that are difficult to accept in a vaccine for a disease that has not been present for >25 years. Herein, we review alternative approaches to maintaining immunity to smallpox through vaccination with attenuated poxviruses, and we suggest modified vaccinia Ankara (MVA) as a leading candidate for an alternative smallpox vaccine.

References

Feb 1, 1992·Pathology, Research and Practice·A Schmitt-Gräff, F Borchard
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G Sutter, B Moss
May 1, 1992·Virology·J TartagliaM Riviere
Nov 27, 1969·The New England Journal of Medicine·J M LaneJ D Millar
Oct 1, 1970·The Journal of Infectious Diseases·J M LaneJ D Millar
Jan 1, 1980·Archives of Virology·G T WernerJ Simon
May 1, 1994·Klinische Monatsblätter für Augenheilkunde·O R Bernasconi, C P Herbort
Apr 1, 1997·The Journal of Infectious Diseases·D J McClainJ A Graham
Jun 15, 1999·JAMA : the Journal of the American Medical Association·D A HendersonK Tonat
Nov 28, 2001·JAMA : the Journal of the American Medical Association·H C Lane, A S Fauci
Dec 19, 2001·Emerging Infectious Diseases·S R RosenthalK L Goldenthal
Jul 4, 2002·Emerging Infectious Diseases·James W LeDucPeter B Jahrling
Oct 17, 2002·JAMA : the Journal of the American Medical Association·John M NeffDonald A Henderson
Oct 25, 2002·Emerging Infectious Diseases·Daniel B JerniganUNKNOWN National Anthrax Epidemiologic Investigation Team
Dec 24, 2002·The New England Journal of Medicine·Samuel A BozzetteMichael A Stoto
Jan 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ingo DrexlerGerd Sutter
Sep 30, 1931·The Journal of Experimental Medicine·T M Rivers, UNKNOWN Technical Assistance of S. M. Ward

❮ Previous
Next ❯

Citations

Feb 11, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Charles J HackettMarshall Plaut
Apr 7, 2005·Nature Medicine·Stanley A Plotkin
Dec 30, 2004·The Journal of Experimental Medicine·David C TscharkeJonathan W Yewdell
Mar 31, 2010·The Journal of Infectious Diseases·Michael S SeamanRaphael Dolin
Jul 8, 2005·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Julie Samia Mair, Michael Mair
Sep 29, 2006·Journal of Virology·Jie TangPhyllis Flomenberg
Aug 13, 2011·Future Virology·Douglas W GrosenbachDennis E Hruby
Apr 9, 2015·Viruses·Lucas Sánchez-SampedroMariano Esteban
Mar 26, 2013·Vaccine·Matthew G Cottingham, Miles W Carroll
Oct 23, 2008·Vaccine·Thomas C GreenoughUNKNOWN Pediatric AIDS Clinical Trials Group P1059 Team
Feb 20, 2008·Reviews in Medical Virology·Andrew W Artenstein
Oct 21, 2006·Vaccine·Julie KennerMarc Gurwith
Feb 7, 2006·Lancet·Zack S MooreJ Michael Lane
Dec 5, 2015·Molecular Therapy. Methods & Clinical Development·Andrea R MooreWeidong Xiao
Jun 1, 2005·Trends in Immunology·Marianne M Stanford, Grant McFadden
Oct 30, 2010·Immunity·Margaret A Liu
Oct 25, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·U DarsowJ Ring
May 6, 2016·Clinical and Vaccine Immunology : CVI·Dorothy I JonesHerman F Staats
Mar 2, 2005·Nature Reviews. Microbiology·Grant McFadden
Feb 6, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Bastiaan A BlokMihai G Netea
May 1, 2006·Expert Review of Clinical Immunology·J Michael Lane
Oct 11, 2008·Expert Review of Vaccines·Andrew W Artenstein, John D Grabenstein
Aug 3, 2011·Expert Review of Vaccines·Joseph W Golden, Jay W Hooper
Dec 13, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caroline L SmithVincenzo Cerundolo
Sep 29, 2020·Frontiers in Immunology·Yue Lu, Leiliang Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.